Incyte (INCY) Cash & Equivalents (2010 - 2026)
Incyte's Cash & Equivalents came in at $3.98 billion for Q2 2026, up 103.7% from $1.95 billion a year earlier and up 15.1% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Incyte's Cash & Equivalents was $3.1 billion, up 83.5% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 15.4% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $1.69 billion in FY2024 (-47.5%), $3.21 billion in FY2023 (+8.9%), $2.95 billion in FY2022 (+43.5%) and $2.06 billion in FY2021 (+36.0%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents in data going back to Q1 2010.
- Year-over-year, Cash & Equivalents has increased for five consecutive quarters, with growth averaging 37.8% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2026 (growth of 103.7%), and the weakest in Q2 2024 (a decline of 68.5%).
- Business Quant data shows INCY's Cash & Equivalents at $3.46 billion (Q1 2026), $3.1 billion (Q4 2025) and $2.46 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Incyte | 23.17 Bn | 8.11 Bn | 1.57 Bn | 3.98 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.98 Bn |
| Mar 31, 2026 | 3.46 Bn |
| Dec 31, 2025 | 3.10 Bn |
| Sep 30, 2025 | 2.46 Bn |
| Jun 30, 2025 | 1.95 Bn |
| Mar 31, 2025 | 1.94 Bn |
| Dec 31, 2024 | 1.69 Bn |
| Sep 30, 2024 | 1.30 Bn |
| Jun 30, 2024 | 987.29 Mn |
| Mar 31, 2024 | 3.35 Bn |
| Dec 31, 2023 | 3.21 Bn |
| Sep 30, 2023 | 3.23 Bn |
| Jun 30, 2023 | 3.13 Bn |
| Mar 31, 2023 | 2.82 Bn |
| Dec 31, 2022 | 2.95 Bn |
| Sep 30, 2022 | 2.69 Bn |
| Jun 30, 2022 | 2.44 Bn |
| Mar 31, 2022 | 2.26 Bn |
| Dec 31, 2021 | 2.06 Bn |
| Sep 30, 2021 | 2.00 Bn |
API Access
Incyte Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();